Stay updated on Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.

Latest updates to the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page
- Check4 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing Revision: v3.6.0, indicating an updated revision of the page’s documents.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedEnrollment status updated to indicate recruitment is closed. New study-navigation sections and a formatting/version update provide clearer guidance on reading the study record and joining the study.SummaryDifference0.4%

- Check25 days agoChange Detected- The page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor update to the page version. The update does not imply changes to the study details or core content.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3. This update reflects a version label change to the page template/display system rather than changes to the study data.SummaryDifference0.1%

- Check68 days agoChange DetectedThe footer release/version indicator for the ClinicalTrials.gov page was updated from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects an interface/backend update rather than a change to the study record content.SummaryDifference0.1%

- Check76 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Imsidolimab in Generalized Pustular Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab in Generalized Pustular Psoriasis Clinical Trial page.